Saturday 17 October 2026
Export MLAB’s income statement to Excel — free account
Mesa Laboratories, Inc.
MLAB Technology Scientific & Technical Instruments
Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025. In the quarter to June 2026, revenue grew 1.00%, EPS fell 42.5%, free cash flow grew 1,503.7% and total debt rose 70.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
122.48
5.26
−4.12%
Follow MLAB
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to March
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 113.57 | 122.35 | 181.21 | 181.90 | 232.88 | 114.21 | 82.86 | 83.68 | 55.45 | 71.07 |
Analyst estimates 2027–2029 Powerpack |
|||
| High | 169.81 | 224.95 | 268.47 | 292.19 | 333.42 | 332.95 | 206.36 | 141.17 | 155.12 | 144.35 | |||||
| People | |||||||||||||||
| People | Employees | 381 | 366 | 347 | 460 | 506 | 681 | 698 | 736 | 730 | 717 | ||||
| Revenue/emp, $m | 0.25 | 0.26 | 0.30 | 0.26 | 0.26 | 0.27 | 0.31 | 0.29 | 0.33 | 0.35 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 94 | 96 | 103 | 118 | 134 | 184 | 219 | 216 | 241 | 249 | ||||
| Gross margin, % | 56.84 | 56.79 | 59.06 | 55.54 | 64.97 | 59.18 | 61.02 | 61.64 | 62.61 | 63.53 | |||||
| EBT | 14 | 0 | 9 | 4 | 2 | 4 | 0 | (276) | 6 | 12 | |||||
| EBT margin, % | 15.26 | 0.31 | 8.36 | 3.28 | 1.72 | 1.94 | (0.18) | (127.50) | 2.47 | 4.82 | |||||
| Net income | 11 | (3) | 7 | 2 | 3 | 2 | 1 | (254) | (2) | 7 | |||||
| Depreciation | 9 | 23 | 14 | 21 | 17 | 11 | 33 | 307 | 26 | 23 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 25.46 | 25.51 | 26.87 | 28.02 | 26.92 | 35.37 | 41.17 | 40.14 | 44.45 | 45.18 | ||||
| Earnings | 3.04 | (0.79) | 1.95 | 0.32 | 0.66 | 0.36 | 0.17 | (47.20) | (0.36) | 1.22 | |||||
| Cash flow | 4.70 | 6.82 | 7.96 | 6.43 | 7.45 | 7.53 | 5.26 | 8.19 | 8.63 | 7.77 | |||||
| Capex | (3.15) | (0.44) | 0.25 | (0.35) | (0.40) | (0.85) | (0.85) | (0.48) | (0.83) | (0.59) | |||||
| Free cash flow | 1.55 | 6.38 | 8.21 | 6.07 | 7.05 | 6.68 | 4.41 | 7.72 | 7.80 | 7.18 | |||||
| Book value | 26.59 | 26.36 | 28.99 | 52.38 | 81.65 | 75.56 | 73.95 | 26.99 | 29.48 | 33.78 | |||||
| Shares, m | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 40.50 | 0.00 | 117.38 | 471.02 | 392.74 | 688.86 | 1,027.82 | 0.00 | 0.00 | 71.89 | ||||
| P/S | 4.82 | 5.58 | 8.52 | 8.07 | 9.04 | 7.21 | 4.24 | 2.79 | 2.67 | 1.96 | |||||
| P/B | 4.61 | 5.40 | 7.89 | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 4.02 | 2.62 | |||||
| EV/Sales | 5.36 | 6.02 | 8.64 | 8.58 | 8.17 | 8.14 | 4.94 | 3.70 | 2.89 | 2.46 | |||||
| EV/FCF | 88.13 | 24.07 | 28.28 | 39.58 | 31.19 | 43.12 | 46.20 | 19.23 | 16.37 | 15.46 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 17 | 26 | 31 | 27 | 37 | 39 | 28 | 44 | 47 | 43 | ||||
| Capex | (12) | (2) | 1 | (1) | (2) | (4) | (5) | (3) | (4) | (3) | |||||
| Free cash flow | 6 | 24 | 32 | 26 | 35 | 35 | 23 | 42 | 42 | 40 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 19 | 15 | 10 | 97 | 271 | 76 | 76 | 65 | (61) | 44 | ||||
| Total debt | 55 | 46 | 23 | 141 | 147 | 221 | 186 | 222 | 81 | 151 | |||||
| Net debt | 49 | 41 | 13 | 60 | (117) | 172 | 153 | 193 | 53 | 125 | |||||
| Shareholders’ equity | 98 | 99 | 111 | 220 | 406 | 394 | 393 | 145 | 160 | 186 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 6.73 | (1.76) | 4.66 | 0.63 | 0.65 | 0.29 | 0.14 | (45.87) | (0.45) | 1.56 | ||||
| ROIC | 6.95 | 0.97 | 4.94 | 1.77 | 2.67 | 0.52 | 0.38 | (50.18) | 4.79 | 3.72 | |||||
| ROE | 12.26 | (3.00) | 7.10 | 1.07 | 1.05 | 0.47 | 0.24 | (94.36) | (1.29) | 3.88 | |||||
Negative figures in brackets.
Fiscal years to Mar 2026 · latest quarter Jun 2026
Charts ten years each
Mesa Laboratories, Inc. vs peers in Scientific & Technical Instruments (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| NOVT Novanta Inc. | $5.1B | 81.0× | 62.9× | +10.27% (above 0%: growing) | +158.33% (above 0%: growing) | +391.84% (above 0%: growing) | 45.49% | 6.79% | Compare |
| VNT Vontier Corporation | $4.5B | 13.7× | 8.6× | −2.17% (below 0%: shrinking) | −67.74% (below 0%: shrinking) | +13.79% (above 0%: growing) | 48.24% | 19.39% | Compare |
| ITRI Itron, Inc. | $3.7B | 13.6× | 15.4× | −7.23% (below 0%: shrinking) | −19.33% (below 0%: shrinking) | −10.13% (below 0%: shrinking) | 40.97% | 13.51% | Compare |
| BMI Badger Meter, Inc. | $3.7B | 29.6× | 27.2× | −6.63% (below 0%: shrinking) | −13.56% (below 0%: shrinking) | −46.19% (below 0%: shrinking) | 40.83% | 17.71% | Compare |
| ITRN Ituran Location and Control Ltd. | $990.9M | 15.3× | 18.0× | +20.73% (above 0%: growing) | +31.34% (above 0%: growing) | +50.20% (above 0%: growing) | 50.91% | 22.67% | Compare |
| VPG Vishay Precision Group, Inc. | $853.3M | 201× | 149× | +11.67% (above 0%: growing) | n/m | −129.99% (below 0%: shrinking) | 38.65% | (0.35%) | Compare |
| MLAB Mesa Laboratories, Inc. | $714.8M | 142× | 76.4× | +1.00% (above 0%: growing) | −42.53% (below 0%: shrinking) | +1,503.73% (above 0%: growing) | 64.87% | 11.69% | |
| USBC USBC, INC. | $173.7M | — (loss-making) | — | −96.18% (below 0%: shrinking) | n/m | +689.02% (above 0%: growing) | 0.00% | 0.00% | Compare |
| SOTK Sono-Tek Corporation | $96.0M | 50.0× | 46.5× | +1.35% (above 0%: growing) | −22.33% (below 0%: shrinking) | +290.80% (above 0%: growing) | 52.88% | 7.29% | Compare |
| Median of peers | $2.3B | 29.6× | 27.2× | −0.41% | −16.44% | +32.00% | 43.23% | 10.40% |
Mesa Laboratories, Inc. (MLAB) key facts
- Strength: Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025.
- Mesa Laboratories, Inc. (MLAB) is a Scientific & Technical Instruments company in the Technology sector, listed on Nasdaq.
- As of October 16, 2026, MLAB traded at $122.48, a market capitalization of $714.8 million.
- Mesa Laboratories, Inc. pays an annual dividend of $0.64 per share, a yield of 0.52%, with a payout ratio of 76.2%.
- Return on equity was 3.88% and debt-to-equity 0.76.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 1.45 (distress zone) for fiscal 2026.